Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Enomoto

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
FEBS Letters|January 25, 2006
High phosphorylation of HBV core protein by two alpha-type CK2-activated cAMP-dependent protein kinases in vitroMasato Enomoto, Yoshitaka Sawano, Seiji Kosuge, et al.
Nature|October 2, 2012
Mitochondrial defect drives non-autonomous tumour progression through Hippo signalling in DrosophilaShizue Ohsawa, Yoshitaka Sato, Masato Enomoto, et al.
The Journal of Biological Chemistry|October 20, 2009
Novel positive feedback loop between Cdk1 and Chk1 in the nucleus during G2/M transitionMasato Enomoto, Hidemasa Goto, Yasuko Tomono, et al.
Biochemical Pharmacology|January 15, 2008
Release of arachidonic acid induced by tumor necrosis factor-alpha in the presence of caspase inhibition: evidence for a cytosolic phospholipase A2alpha-independent pathwayMasaya Shimizu, Yuka Matsumoto, Takeshi Kurosawa, et al.
Biochemical and Biophysical Research Communications|November 6, 2008
Chk1 phosphorylation at Ser286 and Ser301 occurs with both stalled DNA replication and damage checkpoint stimulationYosuke Ikegami, Hidemasa Goto, Tohru Kiyono, et al.
The Journal of Cell Biology|April 25, 2012
Trichoplein and Aurora A block aberrant primary cilia assembly in proliferating cellsAkihito Inoko, Makoto Matsuyama, Hidemasa Goto, et al.
Journal of Cell Science|February 18, 2011
Trichoplein controls microtubule anchoring at the centrosome by binding to Odf2 and nineinMiho Ibi, Peng Zou, Akihito Inoko, et al.
Therapeutic Advances in Medical Oncology|June 30, 2025
Peritoneum carcinomatosis as a favourable prognostic factor for treatment with nanoliposomal irinotecan and fluorouracil plus leucovorin in advanced pancreatic cancerSatoshi Kobayashi, Taito Fukushima, Shun Tezuka, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
FEBS Letters|January 25, 2006
High phosphorylation of HBV core protein by two alpha-type CK2-activated cAMP-dependent protein kinases in vitroMasato Enomoto, Yoshitaka Sawano, Seiji Kosuge, et al.
Nature|October 2, 2012
Mitochondrial defect drives non-autonomous tumour progression through Hippo signalling in DrosophilaShizue Ohsawa, Yoshitaka Sato, Masato Enomoto, et al.
The Journal of Biological Chemistry|October 20, 2009
Novel positive feedback loop between Cdk1 and Chk1 in the nucleus during G2/M transitionMasato Enomoto, Hidemasa Goto, Yasuko Tomono, et al.
Biochemical Pharmacology|January 15, 2008
Release of arachidonic acid induced by tumor necrosis factor-alpha in the presence of caspase inhibition: evidence for a cytosolic phospholipase A2alpha-independent pathwayMasaya Shimizu, Yuka Matsumoto, Takeshi Kurosawa, et al.
Biochemical and Biophysical Research Communications|November 6, 2008
Chk1 phosphorylation at Ser286 and Ser301 occurs with both stalled DNA replication and damage checkpoint stimulationYosuke Ikegami, Hidemasa Goto, Tohru Kiyono, et al.
The Journal of Cell Biology|April 25, 2012
Trichoplein and Aurora A block aberrant primary cilia assembly in proliferating cellsAkihito Inoko, Makoto Matsuyama, Hidemasa Goto, et al.
Journal of Cell Science|February 18, 2011
Trichoplein controls microtubule anchoring at the centrosome by binding to Odf2 and nineinMiho Ibi, Peng Zou, Akihito Inoko, et al.
Therapeutic Advances in Medical Oncology|June 30, 2025
Peritoneum carcinomatosis as a favourable prognostic factor for treatment with nanoliposomal irinotecan and fluorouracil plus leucovorin in advanced pancreatic cancerSatoshi Kobayashi, Taito Fukushima, Shun Tezuka, et al.
Pageof 2